Cargando…

Analysis of naphthoquinone derivatives as topoisomerase I inhibitors using fragment based QSAR

Detalles Bibliográficos
Autores principales:	Virupaksha, Bastikar, Alpana, Gupte, Prashant, Khadke, Uday, Deshpande, Alessandro, Desideri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606175/ http://dx.doi.org/10.1186/1758-2946-5-S1-P22

Ejemplares similares

Quantitative structure–activity relationship-based computational approaches
por: Bastikar, Virupaksha, et al.
Publicado: (2022)

A new software for fragment-based QSAR and its applications
por: Sosnin, Sergey B, et al.
Publicado: (2014)

Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study
por: Prachayasittikul, Veda, et al.
Publicado: (2017)

Automating QSAR expertise
por: Leahy, DE, et al.
Publicado: (2008)

QSAR of anti-inflammatory drugs
por: Khayrullina, Veronica R, et al.
Publicado: (2010)

QSAR Modeling on Benzo[c]phenanthridine Analogues as Topoisomerase I Inhibitors and Anti-cancer Agents
por: Thai, Khac-Minh, et al.
Publicado: (2012)

Surflex-QMOD: physically meaningful QSAR
por: Steudle, Alexander, et al.
Publicado: (2014)

Docking based 3D-QSAR studies applied at the BRAF inhibitors to understand the binding mechanism
por: Mahmood, Uzma, et al.
Publicado: (2012)

On some aspects of validation of predictive QSAR models
por: Roy, K, et al.
Publicado: (2008)

QSAR modelling of acute toxicity in the fathead minnow
por: Zakharov, Alexey, et al.
Publicado: (2008)

Kernel-based estimation of the applicability domain of QSAR models
por: Fechner, Nikolas, et al.
Publicado: (2010)

Updating existing QSAR models: selection and weighting of new data
por: Öberg, Tomas, et al.
Publicado: (2010)

Diagnostic of tautomer behaviour on QSAR models and AM1 optimisation
por: Thalheim, T, et al.
Publicado: (2011)

Reliable estimation of externally validated prediction errors for QSAR models
por: Baumann, Désirée, et al.
Publicado: (2013)

The open state of human topoisomerase I as probed by molecular dynamics simulation
por: Chillemi, Giovanni, et al.
Publicado: (2007)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Sodium dependent glucose transporter (SGLT) 1 / 2 - elucidating inhibitor SAR and selectivity using homology modelling and 3D QSAR studies
por: Vorberg, Susann, et al.
Publicado: (2012)

Topoisomerase II isoforms are required for HIV-1 reverse transcription
por: Sunnam, Lokeswara Balakrishna, et al.
Publicado: (2012)

Prediction of highly-connected 'hub'-proteins in protein interaction networks using QSAR
por: Hsing, M, et al.
Publicado: (2010)

QSPR designer – employ your own descriptors in the automated QSAR modeling process
por: Skřehota, Ondřej, et al.
Publicado: (2012)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

QSAR modeling for In vitro assays: linking ToxCast™ database to the integrated modeling framework “OCHEM”
por: Abdelaziz, Ahmed, et al.
Publicado: (2012)

Building QSAR for HTS in vitro assays - a study for the prediction of Aryl hydrocarbon receptor activators
por: Abdelaziz, Ahmed M, et al.
Publicado: (2013)

Comparison of applicability domains of QSAR models: application to the modelling of the environmental toxicity against Tetrahymena pyriformis
por: Tetko, Igor V, et al.
Publicado: (2008)

Role of the protein in the DNA sequence specificity of the cleavage site stabilized by the camptothecin topoisomerase IB inhibitor: a metadynamics study
por: Coletta, Andrea, et al.
Publicado: (2013)

Recent Advances in Fragment-Based QSAR and Multi-Dimensional QSAR Methods
por: Myint, Kyaw Zeyar, et al.
Publicado: (2010)

Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer
por: Bryant, PE, et al.
Publicado: (2008)

6-(1-oxobutyl)-5,8-dimetoxy-1,4-naphthoquinone inhibits the growth of MCF-7 cells via inhibition of angiogenesis and hypoxia inducible factor alpha
por: Kim, S-H
Publicado: (2005)

Synthesis, Anti-Proliferative Activity Evaluation and 3D-QSAR Study of Naphthoquinone Derivatives as Potential Anti-Colorectal Cancer Agents
por: Acuña, Julio, et al.
Publicado: (2018)

Chemogenomic approach to increase accuracy of QSAR modeling of inhibition activity against five major P450 isoforms
por: Novotarskyi, Sergii, et al.
Publicado: (2013)

QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα
por: Alam, Sarfaraz, et al.
Publicado: (2014)

Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010)

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
por: Prieto Cárdenas, Lina S., et al.
Publicado: (2022)

DrugScorePPI for scoring protein-protein interactions: improving a knowledge-based scoring function by atomtype-based QSAR
por: Krüger, Dennis M, et al.
Publicado: (2010)

Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I – DNA Complex
por: Mancini, Giordano, et al.
Publicado: (2010)

Molecular fragments chemoinformatics
por: Kuhn, Hubert, et al.
Publicado: (2010)

Inhibition of cytotoxic T lymphocyte-induced target cell DNA fragmentation, but not lysis, by inhibitors of DNA topoisomerases I and II
Publicado: (1992)

Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB
por: Ottaviani, Alessio, et al.
Publicado: (2021)

Searching substructures in fragment spaces
por: Ehrlich, H-C, et al.
Publicado: (2011)

The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant
por: Fiorani, Paola, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dh717m4s3n91nh0penebh38u4a